NCT03756285 - Safety and Tolerability Study of AZD4831 in Patients With Heart Failure. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

May 7, 2020

Study Completion Date

May 7, 2020

Conditions

Heart Failure

Interventions

DRUG

AZD4831

AZD4831 tablet taken orally for 90 days.

DRUG

Placebo

Placebo tablet taken orally for 90 days.

Trial Locations (13)

Research Site, Hvidovre

Research Site, Herlev

Research Site, Odense C

Research Site, Aarhus N

Research Site, Turku

Research Site, Lund

Research Site, Gothenburg

Research Site, Chicago

Research Site, Boston

Research Site, Deventer

Research Site, Dordrecht

Research Site, Groningen

Research Site, Stockholm